Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.220
-0.020 (-1.61%)
Sep 28, 2026, 2:12 PM EDT - Market open
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $94.91 million as of September 28, 2026. Its market cap has decreased by -30.72% in one year.
Market Cap
94.91M
Enterprise Value
60.85M
1-Year Change
-30.72%
Ranking
Category
Stock Price
$1.22
ChartMarket Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $94.91M, an increase of 69.48%. That is a compound annual growth rate of 3.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 94.91M | -49.86% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
| May 29, 2012 | 56.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 103.68M |
| Cellectis | 103.39M |
| ProMIS Neurosciences | 101.07M |
| PMV Pharmaceuticals | 100.43M |
| Nutriband | 97.25M |
| Adicet Bio | 97.09M |
| Anixa Biosciences | 96.64M |
| Biomea Fusion | 95.68M |